United States· US:10122-502_964401e1-52e5-4c34-b5b5-d028ce092dd9
Revcovi
A elapegademase product containing elapegademase-lvlr, registered in United States by Chiesi USA, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Elapegademase is registered in 3 of 19 countries.
Countries holding a registration under ATC L03AX21 (elapegademase), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Elapegademase · ATC L03AX21
3 / 19 countries
- Czechiaprice
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- elapegademase-lvlr
- Manufacturer
- Chiesi USA, Inc.
- Country
- United States (US)
- ATC code
- L03AX21
- ATC class
- Elapegademase
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1110122502011 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIAL
Regulatory notes
Same medicine, other countries
Elapegademase in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd941b82-439e-4509-b211-db3c47fa2bc1 GET /v1/drugs/fd941b82-439e-4509-b211-db3c47fa2bc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "9R3D3Y0UHS",
"rxcui": "2059219",
"inchikey": null,
"display_name": "ELAPEGADEMASE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAMUSCULAR",
"productid": "10122-502_964401e1-52e5-4c34-b5b5-d028ce092dd9",
"productndc": "10122-502",
"dosage_form": "INJECTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ELAPEGADEMASE",
"proprietary_name": "Revcovi",
"active_ingred_unit": "mg/mL",
"application_number": "BLA761092",
"marketing_category": "BLA",
"nonproprietary_name": "elapegademase-lvlr",
"start_marketing_date": "20181005",
"active_numerator_strength": "1.6"
}See everything about elapegademase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.